TNF and rheumatoid arthritis: Anti-inflammatory drugs, glucocorticoids and biologics such as TNF antagonists have significantly improved the quality of life of many RA patients; however, a large proportion of them (around 50%) do not respond well to current therapies, become refractory to the treatment, or present increased risk of infections.